Clinical Trial Update: Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG [NA]

View source ↗

Summary

This completed clinical trial evaluated the pathogenesis of stress-induced cardiomyopathy using I-123 MIBG imaging; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takotsubo Cardiomyopathy

Drugs mentioned

• I-123-MIBG (meta-iodobenzylguanidine labeled with iodine-123)

Snippet

Sponsor: University of Pittsburgh | Conditions: Stress Induced Cardiomyopathy | NA | Status: COMPLETED | Results posted: 2016-03-22